This post examines legal safeguards and individual assessment importance in evaluating the EU Safe Countries of Origin list, highlighting potential risks.
The new EU Safe Countries of Origin list promises efficiency but risks rights. This post examines the legal safeguards, CJEU case law, and why individual assessment remains crucial despite the “safe” label.
No takes yet. Share an insight, caveat, or question.
Baya Amouri (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: